This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Luminal B Breast Cancer

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Luminal B Breast Cancer Means

Luminal B breast cancer is a specific subtype of breast cancer that falls under the category of hormone receptor-positive cancers. This means the cancer cells have proteins called estrogen receptors (ER) that respond to the hormone estrogen. However, unlike some other hormone-positive cancers, Luminal B cells often do not have progesterone receptors (PR). Another important feature is that these cancer cells may or may not have the HER2 protein on their surface, which can affect treatment options.

A key biological marker of Luminal B breast cancer is a protein called Ki-67. Ki-67 is found only in cells that are actively dividing, so high levels of Ki-67 suggest the cancer cells are growing and multiplying more quickly than in some other breast cancer types.

Why This Concept Matters in Cancer Care

Knowing whether breast cancer is Luminal B helps doctors understand how the cancer behaves. Luminal B cancers tend to grow faster and may have a slightly less favorable outlook compared to Luminal A breast cancers, which generally grow more slowly. This information can influence treatment decisions, such as the choice of hormone therapies, chemotherapy, or targeted treatments.

However, it is important to remember that Luminal B is just one part of a larger picture. Each person’s cancer is unique, and many factors affect treatment and prognosis.

What Patients Might See or Hear About Luminal B Breast Cancer

Patients may encounter the term Luminal B breast cancer in pathology reports, treatment discussions, or educational materials. It might come up when doctors explain test results that show hormone receptor status, HER2 status, and Ki-67 levels. Because this term relates to how the cancer cells behave, it can be part of conversations about treatment options and expected outcomes.

It’s normal to feel uncertain when hearing this term. Patients and caregivers should feel comfortable asking their care team to explain what Luminal B means for their specific diagnosis and treatment plan.

What Luminal B Breast Cancer Does Not Automatically Mean

Seeing the term Luminal B breast cancer does not by itself determine the exact treatment or prognosis. It does not mean the cancer is aggressive in every case, nor does it guarantee a particular outcome. It also does not replace the need for other important tests and clinical information that doctors use to guide care.

It is not a final diagnosis on its own but rather a description of certain features of the cancer cells that help inform the overall diagnosis and treatment approach.

How to Use This Information and Next Steps

When Luminal B breast cancer appears in your medical records or discussions, the best step is to ask your care team what it means for your individual situation. Questions might include how it affects treatment choices, what tests were done to identify it, and what to expect moving forward.

Remember that this information is educational and does not replace personalized medical advice. Your care team can help interpret this term in the context of your full diagnosis and recommend the safest and most appropriate treatment plan for you.

Sources

Public source information used for this glossary entry includes: